flomoxef has been researched along with Cross Infection in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cheng, A; Chuang, YC; Sheng, WH; Wang, JT; Yang, JJ | 1 |
| Chen, CH; Chen, JB; Chiu, CH; Chuang, FR; Lee, CT; Liu, HT; Wu, CH; Yang, CC | 1 |
| Cheng, J; Hou, X; Xu, Y; Xu, Z; Yang, Q; Zhang, H | 1 |
| Chen, CH; Chen, JB; Chuang, FR; Lee, CH; Lee, CT; Li, SH; Wu, CH; Yang, CC | 1 |
4 other study(ies) available for flomoxef and Cross Infection
| Article | Year |
|---|---|
Impact of broad-spectrum antimicrobial treatment on the ecology of intestinal flora.
Topics: Acinetobacter baumannii; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; beta-Lactams; Cephalosporins; Cross Infection; Drug Resistance, Bacterial; Enterobacteriaceae; Ertapenem; Feces; Female; Fluoroquinolones; Gastrointestinal Microbiome; Humans; Male; Microbial Viability; Middle Aged; Moxifloxacin; Pseudomonas aeruginosa; Taiwan | 2018 |
Nosocomial extended-spectrum beta-lactamase-producing Klebsiella pneumoniae bacteremia in hemodialysis patients and the implications for antibiotic therapy.
Topics: Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; beta-Lactams; Cephalosporins; Cross Infection; Ertapenem; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Renal Dialysis; Retrospective Studies; Treatment Outcome | 2014 |
Flomoxef showed excellent in vitro activity against clinically important gram-positive and gram-negative pathogens causing community- and hospital-associated infections.
Topics: Anti-Bacterial Agents; beta-Lactamases; Cephalosporins; China; Community-Acquired Infections; Cross Infection; Gram-Negative Bacteria; Gram-Positive Bacteria; Hospitals, University; Humans; Microbial Sensitivity Tests; Polymerase Chain Reaction; Sequence Analysis, DNA | 2015 |
Discrepancy between effects of carbapenems and flomoxef in treating nosocomial hemodialysis access-related bacteremia secondary to extended spectrum beta-lactamase producing Klebsiella pneumoniae in patients on maintenance hemodialysis.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Carbapenems; Cephalosporins; Cross Infection; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Renal Dialysis; Retrospective Studies; Survival Analysis; Treatment Outcome | 2012 |